Diagnostics

Siemens Healthineers Receives FDA Premarket Approval of HCV Genotyping Test for Hepatitis C Patients
VERSANT® HCV Genotype 2.0 Assay (LiPA) provides improved accuracy in identification of HCV genotype and subtype for guiding selection of optimal therapeutic treatment for individuals with Hepatitis C
| 2 min read

These new antibodies function in ELISA and lateral flow applications and thus serve as excellent tools for the detection of this parasite
| 1 min read
















